Trial intelligence / Profile preview

Iohexol vs GFR Estimators in HIV Patients

NCT02522338Phase 4Completed

Sponsor
CHU Saint-Etienne
Start
Feb 2011
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of iohexol, sponsored by CHU Saint-Etienne. Started Feb 2011; status: completed.

02

Drugs

iohexol

Beyond the preview

Go deeper on NCT02522338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02522338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call